Relmada Therapeutics (RLMD) null Earnings

5FebConfirmed
May 15
Sep 15
Nov 15
Feb 16
-1.53
-0.9
-0.27
0.36

Details

Expected EPS
-0.42
Actual EPS
-0.22
Surprise EPS
0.2
Surprise Percent
+47.62%

Description

Relmada Therapeutics (RLMD) has reported earnings of -0.22 per share for .

0 Comments

Share your thoughts